Immune-complex vasculitis: role of complement and IgG-Fc receptor functions.

Vasculitis contributes a major component to the pathogenesis of rheumatic diseases and glomerulonephritis. A common feature of these diseases is the presence of serum immune complexes (IC) which may be deposited in blood vessel walls. The modification of the size and solubility of IC by the classical and alternative complement pathways, and the recent demonstration of the role of cellular complement receptors and IgG-Fc receptors in the handling of IC, now allow a better understanding of the pathogenesis of the severe forms of vasculitis. When complement deficiencies are present, the handling of IC is impaired, and vasculitis results. New blood tests for Factor VIII-related antigen, alkaline ribonuclease, plasma thrombospondin, and anti-neutrophil cytoplasmic antibody correlate with the presence of selected types of vasculitis. In addition, tissue thromboplastin release after application of defined tourniquet pressure can also detect subtle blood vessel injury. These new tests may allow diagnosis without risky organ biopsies. Advances in the diagnosis and treatment of vasculitis will also be discussed.

[1]  J. Unkeless Function and heterogeneity of human Fc receptors for immunoglobulin G. , 1989, The Journal of clinical investigation.

[2]  D. Fearon,et al.  Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis , 1988, The Journal of experimental medicine.

[3]  N. Cooper,et al.  CR2 ligands modulate human B cell activation. , 1988, Journal of immunology.

[4]  J. Loike,et al.  Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Berger,et al.  Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies. , 1988, Journal of immunology.

[6]  R. Frade,et al.  Monoclonal and anti-idiotypic anti-EBV/C3d receptor antibodies detect two binding sites, one for EBV and one for C3d on glycoprotein 140, the EBV/C3dR, expressed on human B lymphocytes. , 1988, Journal of immunology.

[7]  F. Finkelman,et al.  Ligand-loaded but not free complement receptors for C3b/C4b and C3d co-cap with cross-linked B cell surface IgM and IgD. , 1988, Journal of immunology.

[8]  D. Fearon Complement, C receptors, and immune complex disease. , 1988, Hospital practice.

[9]  A. Fauci,et al.  Response: The role of trimethoprim/sulfamethoxazole in the treatment of Wegener's granulomatosis , 1988 .

[10]  R. Deremee The treatment of Wegener's granulomatosis with trimethoprim/sulfamethoxazole: illusion or vision? , 1988, Arthritis and rheumatism.

[11]  Clark,et al.  Defect in the membrane expression of high affinity 72-kD Fc gamma receptors on phagocytic cells in four healthy subjects. , 1988, The Journal of clinical investigation.

[12]  R. Winchester,et al.  Up-regulation of the iC3b receptor (CR3) is neither necessary nor sufficient to promote neutrophil aggregation. , 1988, The Journal of clinical investigation.

[13]  N. Hogg,et al.  Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. , 1988, The Journal of clinical investigation.

[14]  P. Schena,et al.  Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy. , 1988, Journal of immunology.

[15]  F. Arnett,et al.  Molecular heterogeneity of complement component C4-null and 21-hydroxylase genes in systemic lupus erythematosus. , 1988, Arthritis and rheumatism.

[16]  R. Deremee,et al.  Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. , 1988, Arthritis and rheumatism.

[17]  W. Druml,et al.  Cyclosporin in Wegener granulomatosis. , 1988, Annals of internal medicine.

[18]  M. Walport,et al.  The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms. , 1988, Journal of immunology.

[19]  G. Stewart,et al.  Quinidine‐induced allergic granulomatous angiitis: an unusual cause of acute renal failure , 1988, The Medical journal of Australia.

[20]  R. Bache,et al.  Wegener's granulomatosis with acute pericardial tamponade. , 1988, Arthritis and rheumatism.

[21]  J. Bonnetblanc,et al.  Dapsone and rheumatoid vasculitis leg ulcerations. , 1988, Journal of the American Academy of Dermatology.

[22]  B. Berggren,et al.  Computed tomography of the brain in cases with venous vasculitis compared with an age-matched reference group. , 1988, Acta radiologica.

[23]  G. Nemerow,et al.  Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment. , 1988, Annual review of immunology.

[24]  D. Houghton,et al.  Inherited C3 deficiency with recurrent infections and glomerulonephritis. , 1988, American journal of diseases of children.

[25]  P. Bacon Vasculitis--clinical aspects and therapy. , 2009, Acta medica Scandinavica. Supplementum.

[26]  C. Wilson Immune aspects of renal diseases. , 1987, JAMA.

[27]  J. Myers,et al.  Wegener's granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. , 1987, The American journal of surgical pathology.

[28]  P. Klein,et al.  Plasma Thrombospondin as an Indicator of Intravascular Platelet Activation in Patients with Vasculitis , 1987, Thrombosis and Haemostasis.

[29]  B. R. Kaye,et al.  Cerebral vasculitis associated with cocaine abuse. , 1987, JAMA.

[30]  J. Axelson,et al.  Wegener granulomatosis and trimethoprim-sulfamethoxazole. , 1987, Annals of internal medicine.

[31]  W. Mccune,et al.  Correlation of angiographic abnormalities with disease manifestations and disease severity in polyarteritis nodosa. , 1987, The Journal of rheumatology.

[32]  S. Pillemer,et al.  IgA related disorders in rheumatoid arthritis. , 1987, The Journal of rheumatology.

[33]  L. Truedsson,et al.  Clinical and serological features of severe vasculitis in rheumatoid arthritis: prognostic implications. , 1987, Annals of the rheumatic diseases.

[34]  L. Guillevin,et al.  Human immunodeficiency virus antibodies and systemic vasculitis. , 1987, Arthritis and rheumatism.

[35]  B. Clotet,et al.  Cutaneous vasculitis associated with propylthiouracil therapy. , 1987, Archives of internal medicine.

[36]  E. H. Epstein,et al.  Severe vasculitis during isotretinoin therapy. , 1987, Archives of dermatology.

[37]  M. Walport,et al.  Inherited deficiency of erythrocyte complement receptor type 1 does not cause susceptibility to systemic lupus erythematosus. , 1987, Arthritis and rheumatism.

[38]  M. Grossman,et al.  Recurrent Cutaneous Vascuiitis in Cystic Fibrosis , 1987 .

[39]  A. Cats,et al.  Diminished uptake and degradation of soluble aggregates of IgG by monocytes of patients with rheumatoid arthritis and vasculitis. , 1987, The Journal of rheumatology.

[40]  K. Upchurch,et al.  Low-dose methotrexate therapy for cutaneous vasculitis of rheumatoid arthritis. , 1987, Journal of the American Academy of Dermatology.

[41]  W. Gross,et al.  Autoantibodies against cytoplasmic structures of neutrophil granulocytes in Wegener's granulomatosis. , 1987, Clinical and experimental immunology.

[42]  T. Hannedouche,et al.  Penicillin-induced hypersensitivity vasculitides. , 1987, The Journal of antimicrobial chemotherapy.

[43]  N. Scharff,et al.  Reversible valvulitis in Wegener's granulomatosis. , 1987, Chest.

[44]  M. Mannik Mechanisms of tissue deposition of immune complexes. , 1987, The Journal of rheumatology. Supplement.

[45]  J. Todd,et al.  Wegener granulomatosis and trimethoprim-sulfamethoxazole. Complete remission after a twenty-year course. , 1987, Annals of internal medicine.

[46]  L. Cerullo,et al.  Phenylpropanolamine: an over-the-counter drug causing central nervous system vasculitis and intracerebral hemorrhage. Case report and review. , 1987, Neurosurgery.

[47]  A. Woolf,et al.  Factor VIII related antigen in the assessment of vasculitis. , 1987, Annals of the rheumatic diseases.

[48]  J. G. Abuelo,et al.  Severe Glomerulonephritis with Late Emergence of Classic Wegener's Granulomatosis: REPORT OF 4 CASES AND REVIEW OF THE LITERATURE , 1987, Medicine.

[49]  G. Kammer,et al.  Cerebral angiography as a guide for therapy in isolated central nervous system vasculitis. , 1987, JAMA.

[50]  P. Schur,et al.  Deficiency of the C3b/C4b receptor (CR1) of erythrocytes in systemic lupus erythematosus: analysis of the stability of the defect and of a restriction fragment length polymorphism of the CR1 gene. , 1987, Journal of immunology.

[51]  J. Snedeker,et al.  Cytomegalovirus infection in an infant presenting with cutaneous vasculitis. , 1987, The Pediatric infectious disease journal.

[52]  V. Tron,et al.  Allergic angiitis of Churg and Strauss syndrome. Response to pulse methylprednisolone. , 1987, Chest.

[53]  F. Malkinson,et al.  Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. , 1987, Journal of the American Academy of Dermatology.

[54]  D. Fearon,et al.  Human C3b/C4b receptor (CR1). Demonstration of long homologous repeating domains that are composed of the short consensus repeats characteristics of C3/C4 binding proteins , 1987, The Journal of experimental medicine.

[55]  S. Pizzo,et al.  Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. , 1987, The American journal of medicine.

[56]  D. Blanchard,et al.  Necrotising vasculitis associated with captopril therapy. , 1987, European heart journal.

[57]  D. Scott,et al.  Polyarteritis and the kidney. , 1987, The Quarterly journal of medicine.

[58]  E. J. Hodges,et al.  Refractory scleritis due to Wegener's granulomatosis. , 1987, The Western journal of medicine.

[59]  Gilbert Gj Churg-Strauss syndrome: determining adequacy of corticosteroid dosage by the eosinophil count. , 1987 .

[60]  L. Rosenbaum,et al.  Serum sickness-like illness and leukocytoclastic vasculitis following intracoronary arterial streptokinase. , 1987, American heart journal.

[61]  V. Schuster,et al.  Coexistent Wegener's granulomatosis and anti-glomerular basement membrane disease. , 1987, Human pathology.

[62]  R. Hené,et al.  Treatment of Wegener's granulomatosis with cyclosporin. , 1987, Annals of the rheumatic diseases.

[63]  Lie Jt The classification and diagnosis of vasculitis in large and medium-sized blood vessels. , 1987 .

[64]  J. A. Oliver,et al.  Systemic vasculitis resembling periarteritis nodosa in the lupus-like syndrome induced by hydralazine. , 1987, American journal of nephrology.

[65]  M. Walport,et al.  Deficiency of the effector mechanisms of the immune response and autoimmunity. , 1987, Ciba Foundation symposium.

[66]  P. Bouche,et al.  Peripheral neuropathy in systemic vasculitis , 1986, Neurology.

[67]  J. Vergnon,et al.  Granulomatose de Wegener: intérêt du lavage broncho-alvéolaire: trois observations , 1986 .

[68]  D. M. Volk,et al.  Cutaneous polyarteritis nodosa in a patient with ulcerative colitis. , 1986, Journal of pediatric gastroenterology and nutrition.

[69]  M. Glassman,et al.  Immune-complex glomerulonephritis in Crohn's disease. , 1986, Journal of pediatric gastroenterology and nutrition.

[70]  M. Shingu,et al.  Serum alkaline ribonuclease derived from vascular endothelial cells is raised in patients with rheumatoid vasculitis. , 1986, Annals of the rheumatic diseases.

[71]  P. Bauret,et al.  [Efficacy of adenine arabinoside (vidarabine) in the treatment of periarteritis nodosa associated with chronic active viral hepatitis B]. , 1986, Gastroenterologie clinique et biologique.

[72]  J. Karsh,et al.  Polyarteritis nodosa presenting as serous otitis media in a patient receiving hyposensitization therapy. , 1986, The Journal of rheumatology.

[73]  J. Schifferli,et al.  The role of complement and its receptor in the elimination of immune complexes. , 1986, The New England journal of medicine.

[74]  A. Kharazmi,et al.  Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease. , 1986, Clinical and experimental immunology.

[75]  Y. Privat,et al.  Vascularite nécrosante cutanéo-systémique survenue en cours de désensibilisation. , 1986 .

[76]  I. Stamenkovic,et al.  Granulomes extra-vasculaires et périvasculaires et vasculite nécrosante associés à l'antigénémie de l'hépatite B , 1986 .

[77]  W. Placek Circulating immune complexes in patients with psoriasis. , 1986, Acta Universitatis Carolinae. Medica.

[78]  F. Cosio,et al.  Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. , 1986, The Journal of clinical investigation.

[79]  J. Mathews,et al.  Defective reticuloendothelial system C3b mediated clearance in rheumatoid arthritis and vasculitis. , 1985, The Journal of rheumatology.

[80]  T. H. The,et al.  AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS , 1985, The Lancet.

[81]  D. Birmingham,et al.  Complement depletion accelerates the clearance of immune complexes from the circulation of primates. , 1984, The Journal of clinical investigation.

[82]  J. Zabriskie,et al.  Immunological studies of post-streptococcal sequelae. Evidence for presence of streptococcal antigens in circulating immune complexes. , 1984, The Journal of clinical investigation.

[83]  P. Lambert,et al.  Capacity to solubilize immune complexes in sera and synovial fluids from patients with rheumatoid arthritis. , 1983, Arthritis and rheumatism.

[84]  D. Birmingham,et al.  Primate erythrocyte-immune complex-clearing mechanism. , 1983, The Journal of clinical investigation.

[85]  B. Haynes,et al.  Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. , 1983, Annals of internal medicine.

[86]  J. Schifferli,et al.  Complement-mediated solubilization in patients with systemic lupus erythematosus, nephritis or vasculitis. , 1981, Clinical and experimental immunology.

[87]  V. Nussenzweig,et al.  Requirements for the solubilization of immune aggregates by complement. The role of the classical pathway. , 1978, The Journal of clinical investigation.

[88]  V. Nussenzweig,et al.  Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes , 1977, The Journal of experimental medicine.

[89]  G. Miller,et al.  A new complement function: solubilization of antigen-antibody aggregates. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[90]  M. Mannik,et al.  Saturation of the reticuloendothelial system with soluble immune complexes. , 1974, Journal of immunology.